AAAAAA

   
Results: 1-5 |
Results: 5

Authors: Marzioni, D Banita, M Felici, A Paradinas, FJ Newlands, E De Nictolis, M Muhlhauser, J Castellucci, M
Citation: D. Marzioni et al., Expression of ZO-1 and occludin in normal human placenta and in hydatidiform moles, MOL HUM REP, 7(3), 2001, pp. 279-285

Authors: Massacesi, C Bascioni, R Cellerino, R Scartozzi, M Bracci, R Alessandroni, P Antognoli, S Ciavattini, A De Nictolis, M Piga, A
Citation: C. Massacesi et al., Cisplatin, epirubicin and cyclophosphamide (PEC) in the treatment of advanced ovarian cancer, J EXP CL C, 19(1), 2000, pp. 13-16

Authors: Campanella, N Ferretti, M Daher, W Pergolini, M De Nictolis, M
Citation: N. Campanella et al., Combined malignant hemangiopericytoma and deep venous thrombosis. A case report, TUMORI, 85(3), 1999, pp. 199-204

Authors: Garzetti, GG Ciavattini, A Lucarini, G Pugnaloni, A De Nictolis, M Amati, S Romanini, C Biagini, G
Citation: Gg. Garzetti et al., Vascular endothelial growth factor expression as a prognostic index in serous ovarian cystoadenocarcinomas: Relationship with MIB1 immunostaining, GYNECOL ONC, 73(3), 1999, pp. 396-401

Authors: Garzetti, GG Ciavattini, A Lucarini, G Pugnaloni, A De Nictolis, M Amati, S Romanini, C Biagini, G
Citation: Gg. Garzetti et al., Expression of vascular endothelial growth factor related to 72-kilodalton metalloproteinase immunostaining in patients with serous ovarian tumors, CANCER, 85(10), 1999, pp. 2219-2225
Risultati: 1-5 |